Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper.

ABSTRACT:

Introduction

Lung cancer is the leading cause of cancer mortality, comprising the largest national cancer disease burden in Australia and New Zealand. Regional reports identify substantial evidence-practice gaps, unwarranted variation from best practice, and variation in processes and outcomes of care between treating centres. The Australia and New Zealand Lung Cancer Registry (ANZLCR) will be developed as a Clinical Quality Registry to monitor the safety, quality and effectiveness of lung cancer care in Australia and New Zealand.

Methods and analysis

Patient participants will include all adults >18 years of age with a new diagnosis of non-small-cell lung cancer (NSCLC), SCLC, thymoma or mesothelioma. The ANZLCR will register confirmed diagnoses using opt-out consent. Data w

SUBMITTER: Smith S 

PROVIDER: S-EPMC9438055 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature